There is broad recognition of the need to address the development and spread of antimicrobial resistance (AMR). A global, systematic analysis estimates that AMR infections lead to 1.27- 4.95 million deaths per year, and resistant bacterial infections are now a leading cause of neonatal mortality worldwide. However, a critical question remains on whether the impact of AMR is being fully understood and quantified throughout medical practice and everyday life, from cancer treatment to food production. Discussions at this workshop will cover current clinical and economic burdens of AMR, data availability and analytical methods, and potential strategies to incorporate these insights.